Exstent Ltd, developer and manufacturer of the ExoVasc® Personalised External Aortic Root Support (PEARS), is pleased to announce that more than 1,400 patients have now received an ExoVasc®.
The device offers an alternative to valve sparing root replacement (VSRR) and total root replacement (TRR) by supporting the aortic wall, preventing further dilatation and negating the requirement for lifelong anti-coagulants. It can also be used to support the pulmonary autograft when the native aortic valve is replaced as part of the Ross procedure.
